AISF position paper on HCV in immunocompromised patients

Antonio Craxi; Vito Di Marco; Salvatore Petta

AISF position paper on HCV in immunocompromised patients

Antonio Craxi, Vito Di Marco, Salvatore Petta

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Risultato della ricerca: Article › peer review

3 Citazioni (Scopus)

Abstract

This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.

Lingua originale	English
pagine (da-a)	10-23
Numero di pagine	14
Rivista	Digestive and Liver Disease
Volume	51
Stato di pubblicazione	Published - 2019

All Science Journal Classification (ASJC) codes

???subjectarea.asjc.2700.2721???
???subjectarea.asjc.2700.2715???

Altri file e collegamenti

Cita questo

@article{4d6932fbb23949c6be51ec8a4b0dafa0,

title = "AISF position paper on HCV in immunocompromised patients",

abstract = "This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.",

author = "Antonio Craxi and {Di Marco}, Vito and Salvatore Petta",

year = "2019",

language = "English",

volume = "51",

pages = "10--23",

journal = "Digestive and Liver Disease",

issn = "1590-8658",

publisher = "Elsevier",

}

TY - JOUR

T1 - AISF position paper on HCV in immunocompromised patients

AU - Craxi, Antonio

AU - Di Marco, Vito

AU - Petta, Salvatore

PY - 2019

Y1 - 2019

N2 - This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.

AB - This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.

UR - http://hdl.handle.net/10447/401686

UR - http://www.elsevier.com/wps/find/journalbibliographicinfo.cws_home/623449/description#bibliographicinfo

M3 - Article

VL - 51

SP - 10

EP - 23

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

ER -

AISF position paper on HCV in immunocompromised patients

Abstract

All Science Journal Classification (ASJC) codes

Altri file e collegamenti

Fingerprint

Cita questo